Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
Antineoplastics

Anastrozole 120511-73-1

Anastrozole 120511-73-1

Anastrozole is a non-steroidal aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and post-menopausal women. The severity of breast cancer can be increased by estrogen, as sex hormones cause hyperplasia, and differentiation at estrogen receptor sites.Anastrozole works by inhibiting the synthesis of estrogen. The patent on Arimidex by AstraZeneca expired June 2010.

Anastrozole 120511-73-1
Appearance:White powder
Cas No:120511-73-1
EINECS:NA
Formula:C17H19N5
Molecular Weight:293.37
Melting Point:81~82 °C
Boiling Point:469.7°C
Flash Point: 237.8°C
Usage:antineoplastics

GMP for anastrozole is available, DMF for anastrozole is under praparation

Disclaimer:Those products ( Anastrozole, anastrazole, anastrozole, 120511-73-1) patented are for lab analytical & research purposes only.